MOUNTAINEER Study: An Effective Treatment Combination For Metastatic Colorectal Cancer

By Oncology Brothers - Last Updated: March 1, 2023

In this podcast episode, the Oncology Brothers (Drs. Rohit & Rahul Gosain) are joined by Dr. Tanios Bekaii-Saab, Mayo Clinic Comprehensive Cancer Center, to discuss the MOUNTAINEER Phase II study, which prompted the FDA approval of tucatinib in combination with trastuzumab in treating advanced colorectal cancer HER2 positive patients.

Post Tags:GI Onc Now VideosGI Oncology
Advertisement
Advertisement
Latest News

December 5, 2023